Brigitte Robertson, MD

Relationship Between ADHD Symptom and Executive Function Improvement in Adult ADHD in SHP465 Mixed Amphetamine Salts Extended-Release Clinical Trials

Adult attention-deficit/hyperactivity disorder (ADHD) is associated with impaired executive function (EF). This post hoc analysis examines relationships between changes in ADHD symptoms a...

Brigitte Robertson , MD;

Jie Chen , MS;

Thomas Brown , PhD;

11/22/2019

Post Hoc Analyses of Remission From 2 Studies of SHP465 Mixed Amphetamine Salts Extended-Release in Adults With Attention-Deficit/Hyperactivity Disorder

In adults with attention-deficit/hyperactivity disorder (ADHD), reductions in ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) were significantly greater with SHP465 mixed amphetamine sal...

Brigitte Robertson , MD;

Lenard Adler , MD;

Elias Sarkis , MD;

Richard Able , PhD;

Jie Chen , MS;

11/22/2019

Post Hoc Responder Analyses of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults With Attention-Deficit/Hyperactivity Disorder

In adults with attention-deficit/hyperactivity disorder (ADHD), SHP465 mixed amphetamine salts (MAS) extended-release reduced ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) significantl...

Lenard Adler , MD;

Elias Sarkis , MD;

Richard Able , PhD;

Jie Chen , MS;

Brigitte Robertson , MD;

11/22/2019

Caregiver Survey of the Burden of Disease in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) face significant disease burden. We evaluated disease burden in children/adolescents with ADHD an...

Sepehr Farahbakhshian , MS;

Brigitte Robertson , MD;

Michael Andreini , BA;

Steven Blahut , MA, PhD;

Eitan Shimko , MS;

Robert Stolper ;

Peter Jensen , MD;

03/01/2019

A Survey of the Burden of Attention-Deficit/Hyperactivity Disorder on Daily Activities and Relationships in Adolescents

Background: Adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) face significant disease burden. This cross-sectional survey evaluated ADHD burden from the perspect...

Michael Andreini , BA;

Steven Blahut , MA, PhD;

Eitan Shimko , MS;

Robert Stolper ;

Peter Jensen , MD;

Sepehr Farahbakhshian , MS;

Brigitte Robertson , MD;

03/01/2019

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of SHP465 Mixed Amphetamine Salts Extended-Release in Children and Adolescents With ADHD: Exploratory Analyses by Age

Objectives: To evaluate SHP465 mixed amphetamine salts (MAS) extended-release efficacy, safety, and tolerability by age group in children and adolescents with attention-deficit/hyperactiv...

Ann Childress , MD;

Ming Yu , MD, PhD;

Brian Yan , PhD;

Brigitte Robertson , MD;

03/01/2019

A Post Hoc Analysis of Relationships Between Executive Function Improvement and ADHD Symptom Improvement With Lisdexamfetamine Dimesylate in Adults With ADHD and Executive Function Deficits

Background: Executive function (EF) deficits are not generally considered synonymous with attention-deficit/hyperactivity disorder (ADHD). Evidence suggests stimulants improve ADHD sympto...

Thomas Brown , PhD;

Victor Otcheretko , MD;

Brigitte Robertson , MD;

Jie Chen , MS;

03/01/2019